IV atropine
Phase 2Small molecule
IV atropine is one of 66 small molecule programs targeting Arrhythmia. It is currently in Phase 2.
3
Indications
5
Total Trials
0
Active Trials
65
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
1931 competitors in COVID-19
#DrugCompanyPhaseTrials
1Spikevax
ModernaPreclinical
Bnt162b2
BioNTechPreclinical
IV atropine
AAssiut University
Phase 2
Proventil
Mylan Pharmaceuticals IncPreclinical
Nadroparin
GSKPreclinical
Glucocorticoid
AbbViePreclinical
Piperacillin/tazobactam
PfizerPreclinical
Orap
TevaPreclinical
HB-Admscs
HHope Biosciences Research Foundation
Preclinical
Interferon-Gamma
SSPP Pharmaclon Ltd.
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
COVID-191 trial
TPA in Acute Stroke With COVID Verus Non-COVID-19 Patients
Completed·—·Phase 1·NCT05258565·50 enrolled
Functional Endoscopic Sinus Surgery1 trial
Efficacy of Oral Diltiazem on the Intraoperative Bleeding in Functional Endoscopic Sinus Surgery
Unknown status·—·Phase 1·NCT03580590·40 enrolled
Agitation1 trial
Effect of Intravenous Nalbuphine on Emergence Agitation
Completed·—·Phase 2·NCT03470077·80 enrolled
Tranexamic Acid1 trial
Reducing Blood Loss During Cesarean Myomectomy With Tranexamic Acid
Completed·—·N/A·NCT03505502·120 enrolled
Arrhythmia1 trial
Brad Arrhythmia Induced by Repeated Succinylcholine During Gynecological Laparoscopic Surgery
Completed·—·Phase 2·NCT02676011·120 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for IV atropine. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 2[1]
- Company
- AAssiut University